Published in J Clin Microbiol on July 01, 2003
Real-time PCR in clinical microbiology: applications for routine laboratory testing. Clin Microbiol Rev (2006) 6.03
Comparative evaluation of three automated systems for DNA extraction in conjunction with three commercially available real-time PCR assays for quantitation of plasma Cytomegalovirus DNAemia in allogeneic stem cell transplant recipients. J Clin Microbiol (2011) 1.27
Clinical utility of viral load in management of cytomegalovirus infection after solid organ transplantation. Clin Microbiol Rev (2013) 0.99
Concurrent genotyping and quantitation of cytomegalovirus gB genotypes in solid-organ-transplant recipients by use of a real-time PCR assay. J Clin Microbiol (2008) 0.97
Sequence diversity in the glycoprotein B gene complicates real-time PCR assays for detection and quantification of cytomegalovirus. J Clin Microbiol (2005) 0.95
Comparison of a duplex quantitative real-time PCR assay and the COBAS Amplicor CMV Monitor test for detection of cytomegalovirus. J Clin Microbiol (2004) 0.92
Congenital cytomegalovirus infection in high-risk Canadian infants: Report of a pilot screening study. Can J Infect Dis Med Microbiol (2010) 0.87
An analysis of regulatory T-cell and Th-17 cell dynamics during cytomegalovirus replication in solid organ transplant recipients. PLoS One (2012) 0.83
Detection of cytomegalovirus in whole blood using three different real-time PCR chemistries. J Mol Diagn (2008) 0.80
Errors in published sequences of human cytomegalovirus primers and probes: do we need more quality control? J Clin Microbiol (2005) 0.75
The role of the cytomegalovirus antigenemia assay in the detection and prevention of cytomegalovirus syndrome and disease in solid organ transplant recipients: A review of the British Columbia experience. Can J Infect Dis Med Microbiol (2005) 0.75
Dextramer reagents are effective tools for quantifying CMV antigen-specific T cells from peripheral blood samples. Cytometry B Clin Cytom (2014) 0.75
Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation. Lancet (2000) 4.67
Monitoring of human cytomegalovirus infections and ganciclovir treatment in heart transplant recipients by determination of viremia, antigenemia, and DNAemia. J Infect Dis (1991) 3.42
Quantitation of cytomegalovirus: methodologic aspects and clinical applications. Clin Microbiol Rev (1998) 2.73
Detection of cytomegalovirus DNA in human specimens by LightCycler PCR. J Clin Microbiol (2000) 2.51
Quantitative analysis of cytomegalovirus load using a real-time PCR assay. J Med Virol (2000) 1.84
Cytomegalovirus antigen detection in peripheral blood leukocytes after allogeneic marrow transplantation. Blood (1992) 1.83
Different real-time PCR formats compared for the quantitative detection of human cytomegalovirus DNA. Clin Chem (1999) 1.77
Glomerulopathy associated with cytomegalovirus viremia in renal allografts. N Engl J Med (1981) 1.77
Evaluation of the COBAS AMPLICOR CMV MONITOR test for detection of viral DNA in specimens taken from patients after liver transplantation. J Clin Microbiol (2000) 1.72
A prospective comparison of molecular diagnostic techniques for the early detection of cytomegalovirus in liver transplant recipients. J Infect Dis (1995) 1.71
Effect of delayed specimen processing on cytomegalovirus antigenemia test results. J Clin Microbiol (1995) 1.66
Quantitative polymerase chain reaction to predict occurrence of symptomatic cytomegalovirus infection and assess response to ganciclovir therapy in renal transplant recipients. J Infect Dis (1998) 1.62
Use of molecular assays in diagnosis and monitoring of cytomegalovirus disease following renal transplantation. J Clin Microbiol (1999) 1.50
Quantitative polymerase chain reaction for human herpesvirus diagnosis and measurement of Epstein-Barr virus burden in posttransplant lymphoproliferative disorder. Clin Chem (1997) 1.48
Comparison of quantitative and qualitative PCR assays for cytomegalovirus DNA in plasma. J Clin Microbiol (2001) 1.45
Evaluation of CMV viral load using TaqMan CMV quantitative PCR and comparison with CMV antigenemia in heart and lung transplant recipients. Transplantation (2001) 1.44
Sequence variation within three important cytomegalovirus gene regions in isolates from four different patient populations. J Clin Microbiol (1998) 1.43
Real-time monitoring of cytomegalovirus infections after stem cell transplantation using the TaqMan polymerase chain reaction assays. Transplantation (2000) 1.43
Comparison of quantitative cytomegalovirus (CMV) PCR in plasma and CMV antigenemia assay: clinical utility of the prototype AMPLICOR CMV MONITOR test in transplant recipients. J Clin Microbiol (2000) 1.32
Cytomegalovirus (CMV) virus load kinetics to predict recurrent disease in solid-organ transplant patients with CMV disease. J Infect Dis (2002) 1.28
Low correlation of human cytomegalovirus DNA amplification by polymerase chain reaction with cytomegalovirus disease in organ transplant recipients. J Med Virol (1994) 1.10
Lack of reactivity to CMV pp65 antigenemia testing in a patient with CMV disease following allogeneic bone marrow transplant. Bone Marrow Transplant (1998) 1.06
Role of the laboratory in diagnosis and management of cytomegalovirus infection in hematopoietic stem cell and solid-organ transplant recipients. J Clin Microbiol (2002) 1.05
Variation within the glycoprotein B gene of human cytomegalovirus is due to homologous recombination. J Gen Virol (1999) 1.02
New molecular assays to predict occurrence of cytomegalovirus disease in renal transplant recipients. J Infect Dis (2000) 1.02
Guidance of ganciclovir therapy with pp65 antigenemia in cytomegalovirus-free recipients of livers from seropositive donors. Transplantation (1996) 1.02
Cytomegalovirus DNA concentration in plasma predicts development of cytomegalovirus disease in kidney transplant recipients. Clin Microbiol Infect (2002) 0.94
Cytomegalovirus infection and disease after liver transplantation. An overview. Dig Dis Sci (1992) 0.93
Detection of cytomegalovirus DNA in human specimens by LightCycler PCR: melting point analysis is mandatory to detect virus strains with point mutations in the target sequence of the hybridization probes. J Clin Microbiol (2001) 0.92
Rapid detection and quantification of CMV DNA in urine using LightCycler-based real-time PCR. J Clin Virol (2002) 0.89
Monitoring of viral load by quantitative plasma PCR during active cytomegalovirus infection of individual liver transplant patients. J Clin Microbiol (2002) 0.86
Performance characteristics of an automated PCR assay for the quantification of cytomegalovirus DNA in plasma. J Virol Methods (2002) 0.81
Ogilvie's syndrome associated with acute cytomegaloviral infection after liver transplantation. Transpl Int (2000) 0.78
Quantitation of CMV by real-time PCR in transfusable RBC units. Transfusion (2002) 0.78
Cytomegalovirus disease in liver transplant recipients: impact of acyclovir prophylaxis. Transplant Proc (1993) 0.78
Design and validation of real-time reverse transcription-PCR assays for detection of pandemic (H1N1) 2009 virus. J Clin Microbiol (2009) 1.76
Increased detection of rotavirus using a real time reverse transcription-polymerase chain reaction (RT-PCR) assay in stool specimens from children with diarrhea. J Med Virol (2004) 1.66
Multiplex real time RT-PCR for the detection and quantitation of norovirus genogroups I and II in patients with acute gastroenteritis. J Clin Virol (2005) 1.64
Impact of genetic polymorphisms in cytomegalovirus glycoprotein B on outcomes in solid-organ transplant recipients with cytomegalovirus disease. Clin Infect Dis (2009) 1.64
Shiga Toxin-Producing Escherichia coli Infection, Antibiotics, and Risk of Developing Hemolytic Uremic Syndrome: A Meta-analysis. Clin Infect Dis (2016) 1.53
Herpes zoster infection following solid organ transplantation: incidence, risk factors and outcomes in the current immunosuppressive era. Am J Transplant (2004) 1.48
Evaluation and validation of real-time reverse transcription-pcr assay using the LightCycler system for detection and quantitation of norovirus. J Clin Microbiol (2004) 1.36
Mandatory reporting of HIV infection and opt-out prenatal screening for HIV infection: effect on testing rates. CMAJ (2003) 1.31
EBV viral load detection in clinical virology. J Clin Virol (2010) 1.31
Epidemiology and genotype analysis of sapovirus associated with gastroenteritis outbreaks in Alberta, Canada: 2004-2007. J Infect Dis (2009) 1.23
Association between handling of pet treats and infection with Salmonella enterica serotype newport expressing the AmpC beta-lactamase, CMY-2. J Clin Microbiol (2003) 1.20
Influence of novel norovirus GII.4 variants on gastroenteritis outbreak dynamics in Alberta and the Northern Territories, Canada between 2000 and 2008. PLoS One (2010) 1.20
Shiga-toxigenic Escherichia coli detection in stool samples screened for viral gastroenteritis in Alberta, Canada. J Clin Microbiol (2010) 1.19
HIV seroprevalence among women opting out of prenatal HIV screening in Alberta, Canada: 2002-2004. Clin Infect Dis (2007) 1.18
Sequence-based typing of genetic targets encoded outside of the O-antigen gene cluster is indicative of Shiga toxin-producing Escherichia coli serogroup lineages. J Med Microbiol (2007) 1.10
Emergence of a new norovirus GII.4 variant and changes in the historical biennial pattern of norovirus outbreak activity in Alberta, Canada, from 2008 to 2013. J Clin Microbiol (2013) 1.10
Enhanced identification of viral and atypical bacterial pathogens in lower respiratory tract samples with nucleic acid amplification tests. J Med Virol (2006) 1.09
The clinical utility of whole blood versus plasma cytomegalovirus viral load assays for monitoring therapeutic response. Transplantation (2011) 1.07
Prevention of congenital rubella syndrome--what makes sense in 2006? Epidemiol Rev (2006) 1.05
A trial of valganciclovir prophylaxis for cytomegalovirus prevention in lung transplant recipients. Am J Transplant (2005) 1.03
Nucleic acid testing for west nile virus RNA in plasma enhances rapid diagnosis of acute infection in symptomatic patients. J Infect Dis (2006) 1.03
Magnitude and determinants of first-time and repeat testing among individuals with newly diagnosed HIV infection between 2000 and 2001 in Alberta, Canada: results from population-based laboratory surveillance. J Acquir Immune Defic Syndr (2004) 1.01
An outbreak of E. coli O157:H7 hemorrhagic colitis associated with unpasteurized gouda cheese. Can J Public Health (2005) 1.01
Outbreak of Neisseria meningitidis, Edmonton, Alberta, Canada. Emerg Infect Dis (2002) 1.00
Epidemic of invasive pneumococcal disease, western Canada, 2005-2009. Emerg Infect Dis (2012) 0.99
In vitro antimicrobial activity of moxifloxacin compared to other quinolones against recent clinical bacterial isolates from hospitalized and community-based cancer patients. Diagn Microbiol Infect Dis (2003) 0.99
Concurrent genotyping and quantitation of cytomegalovirus gB genotypes in solid-organ-transplant recipients by use of a real-time PCR assay. J Clin Microbiol (2008) 0.97
Monitoring of polyomavirus BK virus viruria and viremia in renal allograft recipients by use of a quantitative real-time PCR assay: one-year prospective study. J Clin Microbiol (2007) 0.96
Outbreak of Escherichia coli 0157:H7 infections associated with consumption of beef donair. J Food Prot (2007) 0.95
Dispersal of Mycobacterium tuberculosis via the Canadian fur trade. Proc Natl Acad Sci U S A (2011) 0.95
Isolation and detection of Shiga toxin-producing Escherichia coli in clinical stool samples using conventional and molecular methods. J Med Microbiol (2009) 0.95
Immunoglobulin mimicry by Hepatitis C Virus envelope protein E2. Virology (2005) 0.93
Prospective monitoring of BK polyomavirus infection early posttransplantation in nonrenal solid organ transplant recipients. Transplantation (2008) 0.93
MS-H: a novel proteomic approach to isolate and type the E. coli H antigen using membrane filtration and liquid chromatography-tandem mass spectrometry (LC-MS/MS). PLoS One (2013) 0.92
Clinical, microbiological, and epidemiological findings of an outbreak of Mycobacterium abscessus hand-and-foot disease. Diagn Microbiol Infect Dis (2005) 0.92
Clinical utility of molecular surveillance for cytomegalovirus after antiviral prophylaxis in high-risk solid organ transplant recipients. Transplantation (2011) 0.91
The use of donor and recipient screening for toxoplasma in the era of universal trimethoprim sulfamethoxazole prophylaxis. Transplantation (2008) 0.91
Methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in Canada. Diagn Microbiol Infect Dis (2006) 0.91
Ralstonia pickettii bacteremia associated with pediatric extracorporeal membrane oxygenation therapy in a Canadian hospital. Infect Control Hosp Epidemiol (2007) 0.91
Rapid HIV tests in acute care settings in an area of low HIV prevalence in Canada. J Virol Methods (2010) 0.90
Hepatitis C seroprevalence and risk behaviors in patients attending sexually transmitted disease clinics. Sex Transm Dis (2003) 0.89
Transmission of Mycobacterium tuberculosis Beijing Strains, Alberta, Canada, 1991-2007. Emerg Infect Dis (2013) 0.89
Enhanced enteric virus detection in sporadic gastroenteritis using a multi-target real-time PCR panel: a one-year study. J Med Virol (2013) 0.87
Congenital cytomegalovirus infection in high-risk Canadian infants: Report of a pilot screening study. Can J Infect Dis Med Microbiol (2010) 0.87
Genetic relatedness of noroviruses identified in sporadic gastroenteritis in children and gastroenteritis outbreaks in northern Alberta. J Med Virol (2008) 0.86
Escherichia coli O157:H7 lineages in healthy beef and dairy cattle and clinical human cases in Alberta, Canada. J Food Prot (2009) 0.86
Cost-effectiveness and efficacy of spa, SCCmec, and PVL genotyping of methicillin-resistant Staphylococcus aureus as compared to pulsed-field gel Electrophoresis. PLoS One (2013) 0.86
Herpes simplex virus seroprevalence and risk factors in 2 Canadian sexually transmitted disease clinics. Sex Transm Dis (2005) 0.84
Use of quantitative HIV RNA detection for early diagnosis of HIV infection in infants and acute HIV infections in Alberta, Canada. J Clin Microbiol (2011) 0.84
An assessment of donor-to-recipient transmission patterns of human cytomegalovirus by analysis of viral genomic variants. J Infect Dis (2009) 0.84
The role of photochemical treatment with amotosalen and UV-A light in the prevention of transfusion-transmitted cytomegalovirus infections. Transfus Med Rev (2006) 0.83
Multilocus sequence typing of Escherichia coli O26:H11 isolates carrying stx in canada does not identify genetic diversity. J Clin Microbiol (2005) 0.83
Bordetella pertussis in sporadic and outbreak settings in Alberta, Canada, July 2004-December 2012. BMC Infect Dis (2014) 0.82
Sustained intra- and inter-jurisdictional transmission of tuberculosis within a mobile, multi-ethnic social network: lessons for tuberculosis elimination. Can J Public Health (2010) 0.82
A population-based cohort study of Mycobacterium tuberculosis Beijing strains: an emerging public health threat in an immigrant-receiving country? PLoS One (2012) 0.82
Examining DNA fingerprinting as an epidemiology tool in the tuberculosis program in the Northwest Territories, Canada. Int J Circumpolar Health (2013) 0.81
Chronic norovirus and adenovirus infection in a solid organ transplant recipient. Pediatr Infect Dis J (2008) 0.80
High-Quality Draft Whole-Genome Sequences of 162 Salmonella enterica subsp. enterica Serovar Enteritidis Strains Isolated from Diverse Sources in Canada. Genome Announc (2014) 0.80
The use of unprocessed urine samples for detecting and monitoring BK viruses in renal transplant recipients by a quantitative real-time PCR assay. J Virol Methods (2008) 0.80
The INSTI HIV-1/HIV-2 antibody test: a review. Expert Opin Med Diagn (2013) 0.79
Screening of organ and tissue donors for West Nile virus by nucleic acid amplification--a three year experience in Alberta. Am J Transplant (2008) 0.78
In vitro antimicrobial activity of gatifloxacin compared with other quinolones against clinical isolates from cancer patients. Chemotherapy (2004) 0.78
Differential decay kinetics of human cytomegalovirus glycoprotein B genotypes following antiviral chemotherapy. J Clin Virol (2012) 0.78
The utility of multiple molecular methods including whole genome sequencing as tools to differentiate Escherichia coli O157:H7 outbreaks. Euro Surveill (2015) 0.76
Health care-associated Staphylococcus aureus pneumonia. Can J Infect Dis Med Microbiol (2007) 0.76
Methicillin-resistant Staphylococcus aureus in a Canadian intensive care unit: Delays in initiating effective therapy due to the low prevalence of infection. Can J Infect Dis Med Microbiol (2007) 0.76
Complete Genome Sequences of 16 Canadian Strains of Salmonella enterica subsp. enterica Serovar Enteritidis. Genome Announc (2014) 0.75
Identification and epidemiology of severe respiratory disease due to novel swine-origin influenza A (H1N1) virus infection in Alberta. Can J Infect Dis Med Microbiol (2010) 0.75
Maculopapular rash and tremor are associated with West Nile fever and neurological syndromes. J Neurol Neurosurg Psychiatry (2007) 0.75
Expansion of Shiga Toxin-Producing Escherichia coli by Use of Bovine Antibiotic Growth Promoters. Emerg Infect Dis (2016) 0.75
A shelter-associated tuberculosis outbreak: a novel strain introduced through foreign-born populations. Can J Public Health (2012) 0.75
Pulsed-field gel electrophoresis of Staphylococcus aureus. Methods Mol Biol (2015) 0.75
Correction for Rehman et al., High-Quality Draft Whole-Genome Sequences of 162 Salmonella enterica subsp. enterica Serovar Enteritidis Strains Isolated from Diverse Sources in Canada. Genome Announc (2014) 0.75